Background

• The anticancer efficacy of immune checkpoint inhibitors (ICIs) may be diminished by the loss of diversity in gut microbiota because the microbiota has antitumour effects.
• Opioid analgesia (OA) given for cancer pain influences the diversity and composition of gut microbiota.
• Does OA given during ICI therapy for lung cancer...